Our website is made possible by displaying online advertisements to our visitors.
Please consider supporting us by disabling your ad blocker.

PHARMA

Quarterly rpt on consolidated results for the financial period ended 31/3/2008

PHARMANIAGA BERHAD

Financial Year End

31/12/2008
Quarter1
Quarterly report for the financial period ended31/03/2008
The figureshave not been audited

Attachments

Pharma - 1Q2008.pdf
86 KB

SUMMARY OF KEY FINANCIAL INFORMATION
31/03/2008

 
INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR QUARTER
PRECEDING YEAR
CORRESPONDING
QUARTER
CURRENT YEAR TO DATE
PRECEDING YEAR
CORRESPONDING
PERIOD
31/03/2008
31/03/2007
31/03/2008
31/03/2007
RM'000
RM'000
RM'000
RM'000
1Revenue
309,650
256,235
309,650
256,235
2Profit/(loss) before tax
27,374
10,230
27,374
10,230
3Profit/(loss) for the period
18,982
6,493
18,982
6,493
4Profit/(loss) attributable to ordinary equity holders of the parent
18,545
6,069
18,545
6,069
5Basic earnings/(loss) per share (sen)
17.34
5.67
17.34
5.67
6Proposed/Declared dividend per share (sen)
0.00
0.00
0.00
0.00
 
AS AT END OF CURRENT QUARTER
AS AT PRECEDING FINANCIAL YEAR END
7
Net assets per share attributable to ordinary equity holders of the parent (RM)
3.4400
3.2700

Note: For full text of the above announcement, please access KLSE Web site at www.klse.com.my


Remarks :
No interim ordinary dividend has been declared for the financial period ended 31 March 2008 (2007: nil).

A final tax exempt dividend of 18.0% (2006: 15.0%) on 106,963,188 (2006: 106,963,188) ordinary shares of RM1.00 each in respect of the financial year ended 31 December 2007 was approved by the shareholders at the 10th Annual General Meeting on 22 May 2008. The book closure and payment dates for the final dividend will be on 9 June 2008 and 2 July 2008 respectively.


Announcement Info

Company NamePHARMANIAGA BERHAD  
Stock Name PHARMA    
Date Announced28 May 2008  
CategoryFinancial Results
Reference NoPB-080527-64802